Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pharmacokinetic and Phase II Study of Oral Cyclophosphamide and Oral Topotecan in Children With Recurrent and or Refractory Solid Tumors

NCT00628732 is registered in ClinicalTrials.gov with Children's Medical Center Dallas as lead sponsor.

NCT NCT00628732
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00628732 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pharmacokinetic and Phase II Study of Oral Cyclophosphamide and Oral Topotecan in Children With Recurrent and or Refractory Solid Tumors
Lead sponsor
Children's Medical Center Dallas
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2005
Completion date
February 28, 2007
Enrollment
36 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumors